ET Research Study

QuintilesIMS Global Services is conducting a study to learn which symptoms of ET are the most common, and how these symptoms typically affect the lives of patients who live with the disease. This understanding may help improve how the patient’s experience is accounted for in clinical trials that measure the effect of disease treatments.

We are looking for ET patients with the following criteria:

  1. Patient is ≥18 years of age
  2. Patient has a current diagnosis of Essential Thrombocythemia (ET) and fulfills one of the following:
    • Patient has received hydroxyurea treatment in the past and discontinued it for any reason OR
    • Patient could not receive hydroxyurea because it was contraindicated for the patient
  3. Patient has some self‐reported disease related symptom burden
  4. Patient is physically and mentally able to participate in an 75 minute interview in English to discuss signs, symptoms, and impacts related to ET
  5. Patient is not currently participating in a research study where an investigational agent is being administered
  6. Patient has no prior treatment with any oral JAK inhibitor

Study Information Handout